 | • レポートコード：QYR2104Z1003 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ブレビスカピンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射、ドロップピル）、用途別市場規模（脳血管障害、高血糖、脳血栓症、冠状動脈性心臓病（CHD）、狭心症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ブレビスカピンの市場動向 ・企業の競争状況、市場シェア ・ブレビスカピンの種類別市場規模（錠剤、注射、ドロップピル） ・ブレビスカピンの用途別市場規模（脳血管障害、高血糖、脳血栓症、冠状動脈性心臓病（CHD）、狭心症、その他） ・ブレビスカピンの北米市場規模2016-2027（アメリカ、カナダ） ・ブレビスカピンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ブレビスカピンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ブレビスカピンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ブレビスカピンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Luohe Nanjiecuanquanwei Pharmaceutical、Yangtze Pharmaceutical Group、Shanxi Zhendong Pharmaceutical、Tianjin huairen Pharmaceutical、Tonghua Tianshi Pharmaceutical、Jilin Sichang Pharmaceutical、Yunnan Biovalley Pharmaceutical、Shiyao Yinhu Pharmaceutical、Nanchang Hongyi Pharmaceutical、Yunnan Plant Pharmaceutical、Guangdong Global Pharmaceutical） ・結論 |
Breviscapine is an extract of traditional Chinese medicine in the form of tablets, injections and drops.It has the function of dilating cerebral vessels and anticoagulation.Clinically, it is used to treat cerebral insufficiency, sequelae caused by cerebral hemorrhage, hyperglycemia, cerebral thrombosis, coronary heart disease, angina pectoris and other diseases.
Market Analysis and Insights: Global Breviscapine Market
The global Breviscapine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breviscapine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breviscapine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breviscapine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breviscapine market.
Global Breviscapine Scope and Market Size
Breviscapine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breviscapine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablets
Injection
Dropping Pill
Segment by Application
Cerebrovascular Disease
Hyperglycemia
Cerebral Thrombosis
Coronary Heart Disease (CHD)
Angina Pectoris
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Luohe Nanjiecuanquanwei Pharmaceutical
Yangtze Pharmaceutical Group
Shanxi Zhendong Pharmaceutical
Tianjin huairen Pharmaceutical
Tonghua Tianshi Pharmaceutical
Jilin Sichang Pharmaceutical
Yunnan Biovalley Pharmaceutical
Shiyao Yinhu Pharmaceutical
Nanchang Hongyi Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breviscapine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Injection
1.2.4 Dropping Pill
1.3 Market by Application
1.3.1 Global Breviscapine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cerebrovascular Disease
1.3.3 Hyperglycemia
1.3.4 Cerebral Thrombosis
1.3.5 Coronary Heart Disease (CHD)
1.3.6 Angina Pectoris
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breviscapine Market Perspective (2016-2027)
2.2 Breviscapine Growth Trends by Regions
2.2.1 Breviscapine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breviscapine Historic Market Share by Regions (2016-2021)
2.2.3 Breviscapine Forecasted Market Size by Regions (2022-2027)
2.3 Breviscapine Industry Dynamic
2.3.1 Breviscapine Market Trends
2.3.2 Breviscapine Market Drivers
2.3.3 Breviscapine Market Challenges
2.3.4 Breviscapine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breviscapine Players by Revenue
3.1.1 Global Top Breviscapine Players by Revenue (2016-2021)
3.1.2 Global Breviscapine Revenue Market Share by Players (2016-2021)
3.2 Global Breviscapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breviscapine Revenue
3.4 Global Breviscapine Market Concentration Ratio
3.4.1 Global Breviscapine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breviscapine Revenue in 2020
3.5 Breviscapine Key Players Head office and Area Served
3.6 Key Players Breviscapine Product Solution and Service
3.7 Date of Enter into Breviscapine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breviscapine Breakdown Data by Type
4.1 Global Breviscapine Historic Market Size by Type (2016-2021)
4.2 Global Breviscapine Forecasted Market Size by Type (2022-2027)
5 Breviscapine Breakdown Data by Application
5.1 Global Breviscapine Historic Market Size by Application (2016-2021)
5.2 Global Breviscapine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breviscapine Market Size (2016-2027)
6.2 North America Breviscapine Market Size by Type
6.2.1 North America Breviscapine Market Size by Type (2016-2021)
6.2.2 North America Breviscapine Market Size by Type (2022-2027)
6.2.3 North America Breviscapine Market Size by Type (2016-2027)
6.3 North America Breviscapine Market Size by Application
6.3.1 North America Breviscapine Market Size by Application (2016-2021)
6.3.2 North America Breviscapine Market Size by Application (2022-2027)
6.3.3 North America Breviscapine Market Size by Application (2016-2027)
6.4 North America Breviscapine Market Size by Country
6.4.1 North America Breviscapine Market Size by Country (2016-2021)
6.4.2 North America Breviscapine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Breviscapine Market Size (2016-2027)
7.2 Europe Breviscapine Market Size by Type
7.2.1 Europe Breviscapine Market Size by Type (2016-2021)
7.2.2 Europe Breviscapine Market Size by Type (2022-2027)
7.2.3 Europe Breviscapine Market Size by Type (2016-2027)
7.3 Europe Breviscapine Market Size by Application
7.3.1 Europe Breviscapine Market Size by Application (2016-2021)
7.3.2 Europe Breviscapine Market Size by Application (2022-2027)
7.3.3 Europe Breviscapine Market Size by Application (2016-2027)
7.4 Europe Breviscapine Market Size by Country
7.4.1 Europe Breviscapine Market Size by Country (2016-2021)
7.4.2 Europe Breviscapine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breviscapine Market Size (2016-2027)
8.2 Asia-Pacific Breviscapine Market Size by Type
8.2.1 Asia-Pacific Breviscapine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breviscapine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breviscapine Market Size by Type (2016-2027)
8.3 Asia-Pacific Breviscapine Market Size by Application
8.3.1 Asia-Pacific Breviscapine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breviscapine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breviscapine Market Size by Application (2016-2027)
8.4 Asia-Pacific Breviscapine Market Size by Region
8.4.1 Asia-Pacific Breviscapine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breviscapine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breviscapine Market Size (2016-2027)
9.2 Latin America Breviscapine Market Size by Type
9.2.1 Latin America Breviscapine Market Size by Type (2016-2021)
9.2.2 Latin America Breviscapine Market Size by Type (2022-2027)
9.2.3 Latin America Breviscapine Market Size by Type (2016-2027)
9.3 Latin America Breviscapine Market Size by Application
9.3.1 Latin America Breviscapine Market Size by Application (2016-2021)
9.3.2 Latin America Breviscapine Market Size by Application (2022-2027)
9.3.3 Latin America Breviscapine Market Size by Application (2016-2027)
9.4 Latin America Breviscapine Market Size by Country
9.4.1 Latin America Breviscapine Market Size by Country (2016-2021)
9.4.2 Latin America Breviscapine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breviscapine Market Size (2016-2027)
10.2 Middle East & Africa Breviscapine Market Size by Type
10.2.1 Middle East & Africa Breviscapine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breviscapine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breviscapine Market Size by Type (2016-2027)
10.3 Middle East & Africa Breviscapine Market Size by Application
10.3.1 Middle East & Africa Breviscapine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breviscapine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breviscapine Market Size by Application (2016-2027)
10.4 Middle East & Africa Breviscapine Market Size by Country
10.4.1 Middle East & Africa Breviscapine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breviscapine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Luohe Nanjiecuanquanwei Pharmaceutical
11.1.1 Luohe Nanjiecuanquanwei Pharmaceutical Company Details
11.1.2 Luohe Nanjiecuanquanwei Pharmaceutical Business Overview
11.1.3 Luohe Nanjiecuanquanwei Pharmaceutical Breviscapine Introduction
11.1.4 Luohe Nanjiecuanquanwei Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.1.5 Luohe Nanjiecuanquanwei Pharmaceutical Recent Development
11.2 Yangtze Pharmaceutical Group
11.2.1 Yangtze Pharmaceutical Group Company Details
11.2.2 Yangtze Pharmaceutical Group Business Overview
11.2.3 Yangtze Pharmaceutical Group Breviscapine Introduction
11.2.4 Yangtze Pharmaceutical Group Revenue in Breviscapine Business (2016-2021)
11.2.5 Yangtze Pharmaceutical Group Recent Development
11.3 Shanxi Zhendong Pharmaceutical
11.3.1 Shanxi Zhendong Pharmaceutical Company Details
11.3.2 Shanxi Zhendong Pharmaceutical Business Overview
11.3.3 Shanxi Zhendong Pharmaceutical Breviscapine Introduction
11.3.4 Shanxi Zhendong Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.3.5 Shanxi Zhendong Pharmaceutical Recent Development
11.4 Tianjin huairen Pharmaceutical
11.4.1 Tianjin huairen Pharmaceutical Company Details
11.4.2 Tianjin huairen Pharmaceutical Business Overview
11.4.3 Tianjin huairen Pharmaceutical Breviscapine Introduction
11.4.4 Tianjin huairen Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.4.5 Tianjin huairen Pharmaceutical Recent Development
11.5 Tonghua Tianshi Pharmaceutical
11.5.1 Tonghua Tianshi Pharmaceutical Company Details
11.5.2 Tonghua Tianshi Pharmaceutical Business Overview
11.5.3 Tonghua Tianshi Pharmaceutical Breviscapine Introduction
11.5.4 Tonghua Tianshi Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.5.5 Tonghua Tianshi Pharmaceutical Recent Development
11.6 Jilin Sichang Pharmaceutical
11.6.1 Jilin Sichang Pharmaceutical Company Details
11.6.2 Jilin Sichang Pharmaceutical Business Overview
11.6.3 Jilin Sichang Pharmaceutical Breviscapine Introduction
11.6.4 Jilin Sichang Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.6.5 Jilin Sichang Pharmaceutical Recent Development
11.7 Yunnan Biovalley Pharmaceutical
11.7.1 Yunnan Biovalley Pharmaceutical Company Details
11.7.2 Yunnan Biovalley Pharmaceutical Business Overview
11.7.3 Yunnan Biovalley Pharmaceutical Breviscapine Introduction
11.7.4 Yunnan Biovalley Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.7.5 Yunnan Biovalley Pharmaceutical Recent Development
11.8 Shiyao Yinhu Pharmaceutical
11.8.1 Shiyao Yinhu Pharmaceutical Company Details
11.8.2 Shiyao Yinhu Pharmaceutical Business Overview
11.8.3 Shiyao Yinhu Pharmaceutical Breviscapine Introduction
11.8.4 Shiyao Yinhu Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.8.5 Shiyao Yinhu Pharmaceutical Recent Development
11.9 Nanchang Hongyi Pharmaceutical
11.9.1 Nanchang Hongyi Pharmaceutical Company Details
11.9.2 Nanchang Hongyi Pharmaceutical Business Overview
11.9.3 Nanchang Hongyi Pharmaceutical Breviscapine Introduction
11.9.4 Nanchang Hongyi Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.9.5 Nanchang Hongyi Pharmaceutical Recent Development
11.10 Yunnan Plant Pharmaceutical
11.10.1 Yunnan Plant Pharmaceutical Company Details
11.10.2 Yunnan Plant Pharmaceutical Business Overview
11.10.3 Yunnan Plant Pharmaceutical Breviscapine Introduction
11.10.4 Yunnan Plant Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.10.5 Yunnan Plant Pharmaceutical Recent Development
11.11 Guangdong Global Pharmaceutical
11.11.1 Guangdong Global Pharmaceutical Company Details
11.11.2 Guangdong Global Pharmaceutical Business Overview
11.11.3 Guangdong Global Pharmaceutical Breviscapine Introduction
11.11.4 Guangdong Global Pharmaceutical Revenue in Breviscapine Business (2016-2021)
11.11.5 Guangdong Global Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breviscapine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Injection
Table 4. Key Players of Dropping Pill
Table 5. Global Breviscapine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Breviscapine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breviscapine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Breviscapine Market Share by Regions (2016-2021)
Table 9. Global Breviscapine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Breviscapine Market Share by Regions (2022-2027)
Table 11. Breviscapine Market Trends
Table 12. Breviscapine Market Drivers
Table 13. Breviscapine Market Challenges
Table 14. Breviscapine Market Restraints
Table 15. Global Breviscapine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Breviscapine Market Share by Players (2016-2021)
Table 17. Global Top Breviscapine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breviscapine as of 2020)
Table 18. Ranking of Global Top Breviscapine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Breviscapine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breviscapine Product Solution and Service
Table 22. Date of Enter into Breviscapine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Breviscapine Revenue Market Share by Type (2016-2021)
Table 26. Global Breviscapine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Breviscapine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Breviscapine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Breviscapine Revenue Market Share by Application (2016-2021)
Table 30. Global Breviscapine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Breviscapine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Breviscapine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Breviscapine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Breviscapine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Breviscapine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Breviscapine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Breviscapine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Breviscapine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Breviscapine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Breviscapine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Breviscapine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Breviscapine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Breviscapine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Breviscapine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Breviscapine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Breviscapine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Breviscapine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Breviscapine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Breviscapine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Breviscapine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Breviscapine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Breviscapine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Breviscapine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Breviscapine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Breviscapine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Breviscapine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Breviscapine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Luohe Nanjiecuanquanwei Pharmaceutical Company Details
Table 63. Luohe Nanjiecuanquanwei Pharmaceutical Business Overview
Table 64. Luohe Nanjiecuanquanwei Pharmaceutical Breviscapine Product
Table 65. Luohe Nanjiecuanquanwei Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 66. Luohe Nanjiecuanquanwei Pharmaceutical Recent Development
Table 67. Yangtze Pharmaceutical Group Company Details
Table 68. Yangtze Pharmaceutical Group Business Overview
Table 69. Yangtze Pharmaceutical Group Breviscapine Product
Table 70. Yangtze Pharmaceutical Group Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 71. Yangtze Pharmaceutical Group Recent Development
Table 72. Shanxi Zhendong Pharmaceutical Company Details
Table 73. Shanxi Zhendong Pharmaceutical Business Overview
Table 74. Shanxi Zhendong Pharmaceutical Breviscapine Product
Table 75. Shanxi Zhendong Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 76. Shanxi Zhendong Pharmaceutical Recent Development
Table 77. Tianjin huairen Pharmaceutical Company Details
Table 78. Tianjin huairen Pharmaceutical Business Overview
Table 79. Tianjin huairen Pharmaceutical Breviscapine Product
Table 80. Tianjin huairen Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 81. Tianjin huairen Pharmaceutical Recent Development
Table 82. Tonghua Tianshi Pharmaceutical Company Details
Table 83. Tonghua Tianshi Pharmaceutical Business Overview
Table 84. Tonghua Tianshi Pharmaceutical Breviscapine Product
Table 85. Tonghua Tianshi Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 86. Tonghua Tianshi Pharmaceutical Recent Development
Table 87. Jilin Sichang Pharmaceutical Company Details
Table 88. Jilin Sichang Pharmaceutical Business Overview
Table 89. Jilin Sichang Pharmaceutical Breviscapine Product
Table 90. Jilin Sichang Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 91. Jilin Sichang Pharmaceutical Recent Development
Table 92. Yunnan Biovalley Pharmaceutical Company Details
Table 93. Yunnan Biovalley Pharmaceutical Business Overview
Table 94. Yunnan Biovalley Pharmaceutical Breviscapine Product
Table 95. Yunnan Biovalley Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 96. Yunnan Biovalley Pharmaceutical Recent Development
Table 97. Shiyao Yinhu Pharmaceutical Company Details
Table 98. Shiyao Yinhu Pharmaceutical Business Overview
Table 99. Shiyao Yinhu Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 100. Shiyao Yinhu Pharmaceutical Recent Development
Table 101. Nanchang Hongyi Pharmaceutical Company Details
Table 102. Nanchang Hongyi Pharmaceutical Business Overview
Table 103. Nanchang Hongyi Pharmaceutical Breviscapine Product
Table 104. Nanchang Hongyi Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 105. Nanchang Hongyi Pharmaceutical Recent Development
Table 106. Yunnan Plant Pharmaceutical Company Details
Table 107. Yunnan Plant Pharmaceutical Business Overview
Table 108. Yunnan Plant Pharmaceutical Breviscapine Product
Table 109. Yunnan Plant Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 110. Yunnan Plant Pharmaceutical Recent Development
Table 111. Guangdong Global Pharmaceutical Company Details
Table 112. Guangdong Global Pharmaceutical Business Overview
Table 113. Guangdong Global Pharmaceutical Breviscapine Product
Table 114. Guangdong Global Pharmaceutical Revenue in Breviscapine Business (2016-2021) & (US$ Million)
Table 115. Guangdong Global Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breviscapine Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Injection Features
Figure 4. Dropping Pill Features
Figure 5. Global Breviscapine Market Share by Application: 2020 VS 2027
Figure 6. Cerebrovascular Disease Case Studies
Figure 7. Hyperglycemia Case Studies
Figure 8. Cerebral Thrombosis Case Studies
Figure 9. Coronary Heart Disease (CHD) Case Studies
Figure 10. Angina Pectoris Case Studies
Figure 11. Other Case Studies
Figure 12. Breviscapine Report Years Considered
Figure 13. Global Breviscapine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Breviscapine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Breviscapine Market Share by Regions: 2020 VS 2027
Figure 16. Global Breviscapine Market Share by Regions (2022-2027)
Figure 17. Global Breviscapine Market Share by Players in 2020
Figure 18. Global Top Breviscapine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breviscapine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Breviscapine Revenue in 2020
Figure 20. Global Breviscapine Revenue Market Share by Type (2016-2021)
Figure 21. Global Breviscapine Revenue Market Share by Type (2022-2027)
Figure 22. North America Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Breviscapine Market Share by Type (2016-2027)
Figure 24. North America Breviscapine Market Share by Application (2016-2027)
Figure 25. North America Breviscapine Market Share by Country (2016-2027)
Figure 26. United States Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Breviscapine Market Share by Type (2016-2027)
Figure 30. Europe Breviscapine Market Share by Application (2016-2027)
Figure 31. Europe Breviscapine Market Share by Country (2016-2027)
Figure 32. Germany Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Breviscapine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Breviscapine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Breviscapine Market Share by Region (2016-2027)
Figure 42. China Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Breviscapine Market Share by Type (2016-2027)
Figure 50. Latin America Breviscapine Market Share by Application (2016-2027)
Figure 51. Latin America Breviscapine Market Share by Country (2016-2027)
Figure 52. Mexico Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Breviscapine Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Breviscapine Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Breviscapine Market Share by Country (2016-2027)
Figure 58. Turkey Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Breviscapine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Luohe Nanjiecuanquanwei Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 62. Yangtze Pharmaceutical Group Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 63. Shanxi Zhendong Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 64. Tianjin huairen Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 65. Tonghua Tianshi Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 66. Jilin Sichang Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 67. Yunnan Biovalley Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 68. Shiyao Yinhu Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 69. Nanchang Hongyi Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 70. Yunnan Plant Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 71. Guangdong Global Pharmaceutical Revenue Growth Rate in Breviscapine Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の狭心症治療薬市場規模・現状・予測（2021年-2027年） Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. A…- 世界の脳血管障害市場規模・現状・予測（2021年-2027年） Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is…
- 世界の冠動脈疾患治療市場規模・現状・予測（2021年-2027年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 世界の冠動脈疾患治療市場規模・現状・予測（2021年-2027年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 世界の炎症性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Heart Disease Market The global Inflammatory Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …